Pricing
Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.
Industries
Headquarters
Employees
Links
Full screen
Torsten Mummenbrauer
View all
9 people · 0 jobs
3 people · 0 jobs
4 people · 0 jobs
2 people · 0 jobs
HQ
6 people · 0 jobs
Galapagos
4 followers
Merck
293 followers
Amgen
292 followers
Pierre Fabre
17 followers
Revvity
10 followers
AtriCure
QuellTX
5 followers
Abbott
398 followers
Sanofi
306 followers
Gilead Sciences
163 followers
Regeneron
135 followers
Explore companies